The nomogram also performed well
in subsets of patients at the extremes of weight and renal function (Table 3).
Not exact matches
In a randomized, phase 2 multi-center clinical study, led by Manisha Shah, MD of The Ohio State University Comprehensive Cancer Center — Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC — James), investigators tested the effectiveness of the targeted therapy drug, dabrafenib (pronounced «da bRAF e nib» and marketed as Tafinlar), given alone compared with the same drug given in combination with trametinib (pronounced «tra ME ti nib,» marketed at MeKinist) to treat a subset of advanced papillary thyroid cancer patients with B - raf mutation
In a randomized, phase 2 multi-center clinical study, led by Manisha Shah, MD
of The Ohio State University Comprehensive Cancer Center — Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC — James), investigators tested the effectiveness
of the targeted therapy drug, dabrafenib (pronounced «da bRAF e nib» and marketed as Tafinlar), given alone compared with the same drug given
in combination with trametinib (pronounced «tra ME ti nib,» marketed at MeKinist) to treat a subset of advanced papillary thyroid cancer patients with B - raf mutation
in combination with trametinib (pronounced «tra ME ti nib,» marketed
at MeKinist) to treat a
subset of advanced papillary thyroid cancer
patients with B - raf mutations.
Although it is among the most highly metastatic
of all cancers, multiple myeloma is driven to spread by only a
subset of the myeloma cells within a
patient's body, researchers
at Dana - Farber Cancer Institute have found
in a study presented
at the annual meeting
of the American Society
of Hematology (ASH).
«We found that intensive doses
of statins carry the potential for clearing up the lipid debris that can lead to vision impairment
in a
subset of patients with macular degeneration,» said Joan W. Miller, M.D., the Henry Willard Williams Professor and Chair
of Ophthalmology
at Harvard Medical School and Chief
of Ophthalmology
at Massachusetts Eye and Ear and Massachusetts General Hospital.
The study enrolled 100
patients with de novo coronary lesions 2.25 - 3.50 mm
in diameter and length ≤ 27 mm
in two 50 -
patient cohorts for angiographic, intravascular ultrasound, and clinical assessment
at nine or 24 months, with optical coherence tomography (OCT) performed
in a
subset of 30
patients at multiple time periods.
The rationale for an observational approach is to avoid the morbidity
of lymphadenectomy (specifically to avoid the possibility
of lymphedema) for two
subsets of patients who never manifest isolated recurrence
in the lymph node basin: those who have no melanoma remaining
in the nodal basin and those who experience distant treatment failure
at or before the time
of nodal recurrence.
But that optimism, plus the availability
of FDA - approved drugs with an HDAC inhibitory effect, has also prompted many families to find doctors who will prescribe these drugs, without knowing whether they work, or
at what doses, or
in which
subset of patients.
Some
of the earliest studies
of cancer genomes
in AML noted that, within a single
patient, there were
subsets of mutations present
at lower allele frequencies, suggesting that they're not present
in all cells.
This is an exciting finding as it suggests that the immune responses activated
in at least this
subset of PD
patients resemble those driving autoimmune diseases like multiple sclerosis.
Would you think it is plausible that
at least
in a
subset of patients the psychological symptoms develop as an outgrowth
of the inability to properly store fat?
In a subset of 20 patients who participated in TACT, the levels of toxic metals were measured at baseline and again after receiving a 3 - gram dose of EDTA.14 After treatment, the largest increases of metals were with lead (3700 %) and cadmium (750 %
In a
subset of 20
patients who participated
in TACT, the levels of toxic metals were measured at baseline and again after receiving a 3 - gram dose of EDTA.14 After treatment, the largest increases of metals were with lead (3700 %) and cadmium (750 %
in TACT, the levels
of toxic metals were measured
at baseline and again after receiving a 3 - gram dose
of EDTA.14 After treatment, the largest increases
of metals were with lead (3700 %) and cadmium (750 %).
All
of the case series studies showed improvements
in clinical measures, which indicates that these outcomes can be obtained
in the outpatient practice setting
in at least a
subset of adherent
patients.